- $562.03m
- $353.73m
- $1.00m
Shattuck Labs Inc expected to post a loss of 32 cents a share - Earnings Preview
Shattuck Labs Inc expected to post a loss of 32 cents a share - Earnings Preview
Brief: Shattuck Labs Announces Oral Presentation At Upcoming 20Th Congress Of European Crohn’S And Colitis Organization (Ecco) In Inflammatory Bowel Diseases 2025
Shattuck Labs Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Shattuck Labs Q3 Net Income USD -16.675 Million
Shattuck Labs Inc expected to post a loss of 42 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Dine Brands, Pinterest, Nike
U.S. STOCKS ON THE MOVE-Paychex, Dine Brands, Pinterest
Shattuck Labs plunges on discontinuing development of cancer therapy
U.S. STOCKS ON THE MOVE-Sagimet, Datadog, Clorox
Shattuck Labs falls on discontinuing development of cancer therapy
Brief: Shattuck Labs Q2 Net Income USD -21.552 Million
U.S. RESEARCH ROUNDUP-Brighthouse Financial, Microsoft, Shattuck Labs
Brief: Shattuck Labs Says Sl-172154 Demonstrated A Manageable Interim Safety Profile In Combination With Aza
Brief: Shattuck Labs Announces Orphan Drug Designation Granted By The U.S. FDA For Acute Myeloid Leukemia Treatment
Shattuck Labs Inc reports results for the quarter ended in March - Earnings Summary
Shattuck Labs Inc expected to post a loss of 41 cents a share - Earnings Preview
Brief: Shattuck Labs Q1 Net Income USD -18.504 Million
Brief: Shattuck Labs Announces Appointment Of Clay Siegall And Kate Sasser To Its Board Of Directors